EyePoint (EYPT) Raw Materials (2018 - 2026)
EyePoint (EYPT) reported Raw Materials of $1.2 million for Q1 2026, down 34.86% on a YoY basis from $1.8 million in Q1 2025, and down 5.13% sequentially from $1.2 million in Q4 2025.
EyePoint (EYPT) Raw Materials (2018 - 2026) Analysis & Trends
EyePoint (EYPT) has 9 years of Raw Materials data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Raw Materials fell 34.86% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 34.86% YoY), and the FY2025 full-year result was $1.2 million, down 25.83% from the prior year.
- Raw Materials declined to $1.2 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $1.9 million in Q2 2022 to a low of $1.1 million in Q2 2023.
- A 5-year average of $1.5 million and a median of $1.5 million in 2024 frame the typical range for Raw Materials.
- Across the five-year window, Raw Materials plunged 48.29% in 2022 and jumped 30.58% in 2024, its largest moves.
- Tracing EYPT's Raw Materials over 5 years: stood at $1.4 million in 2022, then slipped by 7.59% to $1.3 million in 2023, then climbed by 27.17% to $1.7 million in 2024, then declined by 25.83% to $1.2 million in 2025, then declined by 5.13% to $1.2 million in 2026.
- Business Quant data shows EYPT's Raw Materials at $1.2 million in Q1 2026, $1.2 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.41 Mn |
| Sep 30, 2022 | 1.70 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 1.63 Mn |
| Dec 31, 2021 | 2.73 Mn |
| Sep 30, 2021 | 2.79 Mn |
| Jun 30, 2021 | 3.14 Mn |